References for thrombolysis lecture by Dr. Rob Stafford, January 2015


Brown SGA, Macdonald SPJ, Hankey GJ. Do risks outweigh benefits in thrombolysis for stroke? BMJ. 2013 Aug 29;347(aug29 1):f5215–5.

Lenzer J. Why we can’t trust clinical guidelines. BMJ (Clinical research ed). 2013 Jun 14;346(jun14 2):f3830–0.

Prasad V, Vandross A, Toomey C, Cheung M, Rho J, Quinn S, et al. A Decade of Reversal: An Analysis of 146 Contradicted Medical Practices. Mayo Clinic Proceedings. Elsevier; 2013 Aug;88(8):790–8. [Full Text]

Shinton R. Questions about authorisation of alteplase for ischaemic stroke. The Lancet. Elsevier Ltd; 2014 Aug 23;384(9944):659–60.

Mann J. Efficacy of Tissue Plasminogen Activator (Tpa) for Stroke: Truths about the NINDS study: setting the record straight. Western Journal of Medicine. 2002;176(3):192. [Full Text]

Godlee, F. How guidelines can fail us. BMJ 2014;349:g5448

Marler, J.R. Early stroke treatment associated with better outcome. Neurology 2000 55;11:1649-1655

Wardraw, J. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev. 2014 Jul 29;7:CD000213. doi: 10.1002/14651858.CD000213.pub3.

Selected FOAMed

Thrombolytics for acute ischaemic stroke,

 SGEM#85: Won’t get fooled again (tPA for CVA)

SGEM#70: The secret of NINDS

SGEM#29: Stroke me, stroke me

Stroke thrombolysis 

The major trials of thrombolytic agents in stroke: Clicking on the trial will hyperlink you to the pubmed abstract page.

Trial Journal Time Primary Benefit Harm
MAST – Italy


Lancet 1995 <6hrs None Increased early death


JAMA 1995 <6hrs None Benefit did not outweigh risk


NEJM 1995 <3hrs None No difference


NEJN 1995 <3hrs 13% absolute mRS at 90d Increased ICH


NEJM 1996 <6hrs None Stopped due to harm


JAMA 1996 <4hrs None Stopped due to harm


Lancet 1998 <6hrs None Increased ICH


JAMA 1999 3-4hrs None Stopped unlikely benefit, increased ICH


Stroke 2000 <6hrs None Stopped early due to harm, mortality at 90d 23% vs 7%


NEJM 2008 3-4.5hrs 7% absolute benefit Increased ICH


Lancet 2009 3-9hrs None Increased ICH


Lancet 2012 <6hrs None Increased early death

One thought on “References for thrombolysis lecture by Dr. Rob Stafford, January 2015

  1. This is a fantastic piece of work.

    Your presentation made me rethink the received wisdom from the Stroke Physicians and Pharma.

    I’ll look at the evidence in more detail and reach a decision. What saddens me is that people will still be thrombolysed, regardless of what the evidence says.


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s